Figure 4: The six biomarkers that were regulated differently in SFSBP and its constituent groups. (A) sham group, (B) MI group, (C) SFSBP group, (D) ginsenoside Rb1, (E) ginsenoside Re, (F) bufalin, (G) cinnamic acid, (H) muscone, (I) borneol, and (J) cholic acid. *P < 0.05 and **P < 0.01 when compared with MI group; #P < 0.05, ##P < 0.01 when compared with sham group. The number on the y-axis represents the peak areas of these biomarkers.